Literature DB >> 1942254

The quaternary structure, antigenicity, and aggregational behavior of the secretory core protein of human hepatitis B virus are determined by its signal sequence.

H J Schlicht1, G Wasenauer.   

Abstract

Human hepatitis B virus encodes a secretory core protein, referred to as the HBe protein, whose secretion is mediated by the pre-C signal sequence. Here we examined whether this sequence is important only for translocation of the HBe precursor (the precore protein) or whether it also contributes to the structural and biophysical properties of the mature HBe protein. When a truncated hepatitis B virus precore protein, lacking the basic C-terminal domain which is cleaved from the wild-type protein during its conversion into HBe, was expressed in human hepatoma cells, only a small amount of HBe-like protein was produced. This protein was slightly smaller than the wild-type HBe protein, suggesting that C-terminal cleavage of the precore protein does not occur at the suggested site. When the authentic signal sequence of the precore protein (the pre-C sequence) was replaced by the unrelated signal sequence of an influenza virus hemagglutinin, not only the full-length but also the C-terminally truncated protein was expressed and secreted with high efficiency. Western blot (immunoblot) analyses with nonreducing gels and conformation-specific monoclonal antibodies revealed that the HBe protein secreted under control of the pre-C signal sequence was a monomer with HBe antigenicity, whereas the HBe-like protein secreted under control of the hemagglutinin signal sequence was a disulfide-bridge-linked dimer with both HBe and HBc antigenicity. Electron microscopic examination of gradient-purified particulate core gene products showed that HBe protein secreted under control of the hemagglutinin signal sequence forms core particles, whereas HBe protein secreted under control of the pre-C sequence does not. Thus, the pre-C sequence not only mediates the secretion but also determines the structural and aggregational properties of the HBe protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942254      PMCID: PMC250773     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

2.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

Authors:  D R Milich; J E Jones; J L Hughes; J Price; A K Raney; A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Patterns of amino acids near signal-sequence cleavage sites.

Authors:  G von Heijne
Journal:  Eur J Biochem       Date:  1983-06-01

4.  Electron microscopy of hepatitis B core antigen synthesized in E. coli.

Authors:  B J Cohen; J E Richmond
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  Hepatitis B e antigen polypeptides isolated from sera of individuals infected with hepatitis B virus: comparison with HBeAg polypeptide derived from Dane particles.

Authors:  K Takahashi; M Imai; T Gotanda; T Sano; A Oinuma; S Mishiro; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

6.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

7.  Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

Authors:  M Imai; M Nomura; T Gotanda; T Sano; K Tachibana; H Miyamoto; K Takahashi; S Toyama; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Immunochemical structure of hepatitis B e antigen in the serum.

Authors:  K Takahashi; A Machida; G Funatsu; M Nomura; S Usuda; S Aoyagi; K Tachibana; H Miyamoto; M Imai; T Nakamura; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  The conversion of hepatitis B core antigen synthesized in E coli into e antigen.

Authors:  P MacKay; J Lees; K Murray
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

10.  Monoclonal antibodies to hepatitis Be antigen (HBeAg) derived from hepatitis B core antigen (HBcAg): their use in characterization and detection of HBeAg.

Authors:  R B Ferns; R S Tedder
Journal:  J Gen Virol       Date:  1984-05       Impact factor: 3.891

View more
  12 in total

1.  Comparison of three different recombinant hepatitis B virus core particles expressed in Escherichia coli.

Authors:  A Maassen; A Rehfeldt; S Kiessig; A Ladhoff; W E Höhne; H Meisel
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 2.  Precore/core region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Seung Yeon Do; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

3.  Posttranscriptional regulation of hepatitis B virus replication by the precore protein.

Authors:  P P Scaglioni; M Melegari; J R Wands
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Relevance of cysteine residues for biosynthesis and antigenicity of human hepatitis B virus e protein.

Authors:  G Wasenauer; J Köck; H J Schlicht
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice.

Authors:  L G Guidotti; B Matzke; C Pasquinelli; J M Shoenberger; C E Rogler; F V Chisari
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  A cysteine and a hydrophobic sequence in the noncleaved portion of the pre-C leader peptide determine the biophysical properties of the secretory core protein (HBe protein) of human hepatitis B virus.

Authors:  G Wasenauer; J Köck; H J Schlicht
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  An intramolecular disulfide bridge between Cys-7 and Cys61 determines the structure of the secretory core gene product (e antigen) of hepatitis B virus.

Authors:  M Nassal; A Rieger
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme.

Authors:  Kiyoaki Ito; Kyun-Hwan Kim; Anna Suk-Fong Lok; Shuping Tong
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

9.  The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.

Authors:  Yi-Ling Wang; Gan-Guang Liou; Chao-Hsiung Lin; Mong-Liang Chen; Tzer-Min Kuo; Kuen-Nan Tsai; Chien-Choao Huang; Ya-Ling Chen; Li-Rung Huang; Yu-Chi Chou; Chungming Chang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

10.  Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.

Authors:  B C Gil-Torregrosa; A Raúl Castaño; M Del Val
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.